Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Schering AG to transfer oxybutynin incontinence ring to Barr

April 13, 2004

Preference for tadalafil among patients with erectile dysfunction

April 13, 2004

Tamsulosin improves symptoms and quality of life in patients with CP/CPPS

April 13, 2004

Vardenafil improves erection and depression in patients with erectile dysfunction

April 8, 2004

Novel ALK5 inhibitors prepared and tested by GSK team

April 6, 2004

Alfuzosin reduces need for surgery in acute urinary retention

April 2, 2004

Beta adrenergic receptor targeted for treatment of male sexual dysfunction

April 2, 2004

Studies find dutasteride effective in benign prostatic hyperplasia

April 1, 2004

RO-3202904 may be better tolerated than other overactive bladder treatments

April 1, 2004

New data on tamsulosin presented at the 19th EAU congress

April 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.